Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Samsioe G et al. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate. 2002 Sep-Oct Menopause pmid:12218722
Tang G et al. Controlled delivery system for norethindrone based on biodegradable poly-alpha,beta-(hydroxyalkyl)-DL-aspartamide. 2002 Oct-Dec Drug Deliv pmid:12511199
Schnare SM Progestin contraceptives. 2002 May-Jun J Midwifery Womens Health pmid:12071381
Brynhildsen J and Hammar M Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women. 2002 Mar-Apr Menopause pmid:11875333
Zitzmann M et al. Contraceptive steroids influence the hemostatic activation state in healthy men. 2002 Jul-Aug J. Androl. pmid:12065457
Georgiev DB and Manassiev NA Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women. 2002 Jul-Aug Medscape Womens Health pmid:12466733
Mueck AO et al. Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. 2002 Jul-Aug Menopause pmid:12082363
Mitwally MF et al. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. 2002 Jul-Aug Menopause pmid:12082359
Johnson JV et al. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. 2002 Jan-Feb Menopause pmid:11791082
Niskanen L et al. Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women? 2002 Jan-Feb Menopause pmid:11791086
Konno A et al. Oral contraceptives worsen endotoxin-induced liver injury in rats. 2002 Alcohol. Clin. Exp. Res. pmid:12198379
Affandi B Injectable contraceptives: a worldwide perspective. 2002 J Fam Plann Reprod Health Care pmid:16259804
Garnero P et al. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial. 2002 Hum. Reprod. pmid:12351557
Rolf C et al. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation. 2002 Clin. Endocrinol. (Oxf) pmid:12030915
Swanton AG and Paterson-Brown S Secondary amenorrhoea due to the use of rifampicin as an antimycobacterial agent. 2002 J Obstet Gynaecol pmid:12528712
Kubli-Garfias C et al. Ab initio electronic structure of the progestogen norethisterone and its 5 alpha-derivatives. 2002 J. Steroid Biochem. Mol. Biol. pmid:12589946
Lundström E et al. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. 2002 Am. J. Obstet. Gynecol. pmid:11967497
Skouby SO et al. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. 2002 Am. J. Obstet. Gynecol. pmid:12015523
Salobir BG et al. A randomized, placebo-controlled trial of the effects of continuous combined hormone replacement therapy on coagulation and fibrinolytic systems in healthy postmenopausal women. 2002 Fertil. Steril. pmid:12477508
Lidor AL et al. Effect of raloxifene on the ovarian circulation in women after menopause. 2002 Am. J. Obstet. Gynecol. pmid:12015525
Martínez C et al. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy. 2002 Br. J. Cancer pmid:12237780
Kamischke A et al. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. 2002 J. Clin. Endocrinol. Metab. pmid:11836281
Goudev A et al. Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. 2002 Maturitas pmid:12270582
Perry W and Wiseman RA Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: effect on lipids, coagulation factors, haematology and biochemistry. 2002 Maturitas pmid:12065175
Tatsumi H et al. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. 2002 Maturitas pmid:12191851
Hodgson H Hormonal therapy for gastrointestinal angiodysplasia. 2002 Lancet pmid:12020519
Smit J et al. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa. 2002 Soc Sci Med pmid:12297238
Mildvan D et al. Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women. 2002 J. Acquir. Immune Defic. Syndr. pmid:11981363
Graff-Iversen S and Tonstad S Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey. 2002 Contraception pmid:12169374
Mueck AO et al. Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women. 2002 Maturitas pmid:12385856
Christodoulacos G et al. Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women. 2002 Maturitas pmid:12020983
Norris LA et al. Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. 2002 Maturitas pmid:12385861
Rolf C et al. Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men. 2002 Eur. J. Endocrinol. pmid:11980623
Wells M et al. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study. 2002 BMJ pmid:12153918
van Vliet HA et al. Biphasic versus triphasic oral contraceptives for contraception. 2002 Contraception pmid:12057781
Simsek T et al. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system. 2002 Maturitas pmid:12161049
Von Holst T et al. [Amenorrhea rate after switch from sequential hormone replacement therapy to continuous combined administration of low dose estradiol and norethisterone acetate]. 2002 Zentralbl Gynakol pmid:12439764
Grinspoon S et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. 2002 J. Clin. Endocrinol. Metab. pmid:12050268
Furlong LA Ectopic pregnancy risk when contraception fails. A review. 2002 J Reprod Med pmid:12497674
W Freeman E Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause. 2002 Dialogues Clin Neurosci pmid:22033555
Perera M et al. Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. 2002 Hum. Reprod. pmid:11821303
Verhoeven CH et al. Identification of the human P450 enzymes involved in the in vitro metabolism of the synthetic steroidal hormones Org 4060 and Org 30659. 2002 Xenobiotica pmid:11871398
Nerbrand C et al. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides. 2002 Maturitas pmid:12020980
Oehler MK et al. Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia. 2002 Cancer Lett. pmid:12183078
Moore KH et al. The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers. 2002 Clin Ther pmid:12501881
Ranta V et al. National differences in lipid response to postmenopausal hormone replacement therapy. 2002 Maturitas pmid:12191848
Posaci C et al. The values of urinary NTx in postmenopausal women undergoing HRT; the role of additional alendronate therapy. 2002 Maturitas pmid:12191850
Loh FH et al. The efficacy of two dosages of a continuous combined hormone replacement regimen. 2002 Maturitas pmid:11836043
von Holst T et al. Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone. 2002 Maturitas pmid:12468135
Skarda J Sensitivity and specificity of the bioassay of estrogenicity in mammary gland and seminal vesicles of male mice. 2002 Physiol Res pmid:12234119
Neill AC et al. A comparison of clinical assessment with ultrasound in the management of secondary postpartum haemorrhage. 2002 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:12206921
Silva EG et al. Peritoneal lesions in guinea pigs treated with hormones. 2002 Int. J. Gynecol. Pathol. pmid:12352191
Denton AS et al. Systematic review for non-surgical interventions for the management of late radiation proctitis. 2002 Br. J. Cancer pmid:12107832
Mangat H et al. Poly A RNA status and expression of milli (m) and micro (μ) calpains in skeletal muscle of duchenne muscular dystrophy patients. 2002 Indian J Clin Biochem pmid:23105354
Panay N et al. Low dose 25 mg oestradiol implants and 1 mg norethisterone as continuous combined hormone therapy: a prospective study. 2002 BJOG pmid:12197380
Ylikorkala O et al. Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate. 2002 Acta Obstet Gynecol Scand pmid:12190841
Ramachandra SG et al. Effect of chronic administration of 7alpha-methyl-19-nortestosterone on serum testosterone, number of spermatozoa and fertility in adult male bonnet monkeys (Macaca radiata). 2002 Reproduction pmid:12141943
Ekhato IV et al. Norethindrone acetate (NA) and ethinyl estradiol (EE) related oxidative transformation products in stability samples of formulated drug product: synthesis of authentic references. 2002 Steroids pmid:11856540
Surrey ES and Hornstein MD Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. 2002 Obstet Gynecol pmid:11978277
Schwartz JI et al. Effect of rofecoxib on the pharmacokinetics of chronically administered oral contraceptives in healthy female volunteers. 2002 J Clin Pharmacol pmid:11831545
Grant EC Avoid hormones in gastrointestinal angiodysplasia. 2002 Lancet pmid:12401283
Pasapera AM et al. Norethisterone is bioconverted to oestrogenic compounds that activate both the oestrogen receptor alpha and oestrogen receptor beta in vitro. 2002 Eur. J. Pharmacol. pmid:12359276
Facchinetti F et al. Hormone supplementation differently affects migraine in postmenopausal women. 2002 Headache pmid:12390622
Coppola A et al. Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 2002 J. Intern. Med. pmid:12270009
Skarda J Sensitivity and specificity of bioassay of estrogenicity on mammary gland and uterus of female mice. 2002 Physiol Res pmid:12449440
Cheng S et al. Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women. 2002 Bone pmid:12110425
Morabito N et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. 2002 J. Bone Miner. Res. pmid:12369794
Kawecka-Jaszcz K et al. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. 2002 J Hum Hypertens pmid:12080436
Madsen JS et al. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study. 2002 Am. J. Obstet. Gynecol. pmid:12114885
Riis BJ et al. Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review. 2002 Am. J. Obstet. Gynecol. pmid:12389012
Martinez G et al. Effect of norethisterone and its A-ring reduced metabolites on the acrosome reaction in porcine spermatozoa. 2002 Andrologia pmid:12390087
Milewicz T et al. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor. 2002 Gynecol. Endocrinol. pmid:12396561
Campagnoli C et al. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate. 2002 Maturitas pmid:12034517
Bladbjerg EM et al. Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. 2002 Hum. Reprod. pmid:12456630
Bjarnason NH et al. Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent. 2002 Bone pmid:11934658
Norethisterone. 2002 Rep Carcinog pmid:15328588
Yamasaki K et al. Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. 2002 Toxicology pmid:11750080
Simon JA and Symons JP Unscheduled bleeding during initiation of continuous combined hormone replacement therapy: a direct comparison of two combinations of norethindrone acetate and ethinyl estradiol to medroxyprogesterone acetate and conjugated equine estrogens. 2001 Sep-Oct Menopause pmid:11528357
Ventura P et al. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. 2001 Jul-Aug Menopause pmid:11449082
Walker RJ et al. The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. 2001 Jan-Feb Menopause pmid:11201511
Seeger H et al. Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. 2001 Jan-Feb Menopause pmid:11201515
Ursic-Vrscaj M et al. Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. 2001 Jan-Feb Menopause pmid:11201519
Godsland IF Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. 2001 Fertil. Steril. pmid:11334901
Harwood B and Mishell DR Contraceptive vaginal rings. 2001 Semin. Reprod. Med. pmid:11727180
Haines CJ et al. The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. 2001 Atherosclerosis pmid:11730828
Bruhat M et al. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study. 2001 Maturitas pmid:11731187
Mousa HA and Thong J Omental pregnancy in a woman taking the progestogen-only pill. 2001 Acta Obstet Gynecol Scand pmid:11846713
Herkert O et al. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. 2001 Circulation pmid:11733402
Wihlbäck AC et al. Sensitivity to a neurosteroid is increased during addition of progestagen to postmenopausal hormone replacement therapy. 2001 Neuroendocrinology pmid:11408781
Ahmad ME et al. Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro. 2001 Mutat. Res. pmid:11423341
Smit J et al. Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa. 2001 BMC Health Serv Res pmid:11401729
Blom MJ et al. Metabolism of norethisterone and norethisterone derivatives in rat uterus, vagina, and aorta. 2001 Drug Metab. Dispos. pmid:11408363
Guzic-Salobir B et al. Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women. 2001 J. Intern. Med. pmid:11902819
Bulent Tiras M et al. Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters. 2001 Contraception pmid:11368988
Endrikat J et al. Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations. 2001 Contraception pmid:11747870
Høibraaten E et al. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. 2001 Thromb. Haemost. pmid:11372667
Odmark IS et al. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. 2001 Am. J. Obstet. Gynecol. pmid:11349178
Høibraaten E et al. Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial. 2001 Br. J. Haematol. pmid:11703344
Inglis AM et al. Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers. 2001 J Clin Pharmacol pmid:11402638
Van Vliet H et al. Biphasic versus monophasic oral contraceptives for contraception. 2001 Cochrane Database Syst Rev pmid:11406026